Total planned funding: $611,355,986
Clear active filters
Côte d'Ivoire
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Côte d'Ivoire | $611,355,986 |
Organizational Types
Private Contractor | $214,212,835 |
NGO | $194,398,270 |
Unknown | $54,765,128 |
Own Agency | $50,405,276 |
University | $38,293,455 |
Implementing Agency | $26,974,240 |
Host Country Government Agency | $22,516,781 |
FBO | $5,650,001 |
Other USG Agency | $3,440,000 |
Multi-lateral Agency | $700,000 |
Program Areas
Treatment | $215,899,053 |
Care | $118,850,051 |
Prevention | $115,568,833 |
Governance and Systems | $88,567,417 |
Management and Operations | $39,720,239 |
Testing | $32,750,393 |
Budget Codes
HTXD: Treatment: ARV Drugs | $120,037,963 |
HTXS: Treatment: Adult Treatment | $85,829,914 |
HKID: Care: Orphans and Vulnerable Children | $50,626,779 |
HBHC: Care: Adult Care and Support | $41,510,645 |
HVMS: Management and Operations | $39,720,239 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $39,318,496 |
OHSS: Health Systems Strengthening | $37,384,944 |
HVCT: Testing: HIV Testing and Counseling | $32,750,393 |
HVOP: Sexual Prevention: Other Sexual Prevention | $30,906,448 |
HLAB: Laboratory Infrastructure | $28,584,985 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $23,441,880 |
HVSI: Strategic Information | $22,597,488 |
HVTB: Care: TB/HIV | $17,878,779 |
HMBL: Biomedical Prevention: Blood Safety | $16,550,516 |
PDTX: Treatment: Pediatric Treatment | $10,031,176 |
PDCS: Care: Pediatric Care and Support | $8,833,848 |
HMIN: Biomedical Prevention: Injection Safety | $5,351,493 |
Top Partner Programs
Not Available:
$58,455,865
Countries/Regions
USG Aggregated Agencies:
$26,472,182
Countries/Regions
Côte d'Ivoire
2010 | $13,429,714 |
2011 | $7,580,000 |
2012 | $5,462,468 |
ACONDA:
$26,444,500
Countries/Regions